Latest News about ATAI
Recent news which mentions ATAI
   Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today
   
  
  
  January 25, 2022
  From Benzinga
 
   Psychedelic Stock Gainers And Losers From January 24, 2022
   
  
  
  January 24, 2022
  From Benzinga
 
   Psychedelic Stock Gainers And Losers From January 21, 2022
   
  
  
  January 21, 2022
  From Benzinga
 
   Psychedelic Stock Gainers And Losers From January 20, 2022
   
  
  
  January 20, 2022
  From Benzinga
 From Benzinga
 
   Psychedelic Stock Gainers And Losers From January 18, 2022
   
  
  
  January 18, 2022
  From Benzinga
 
   Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
   
  
  
  January 18, 2022
  From Benzinga
 
   Psychedelic Stock Gainers And Losers From January 17, 2022
   
  
  
  January 17, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
   
  
  
  January 12, 2022
  From Benzinga
 
   Why Jim Cramer Likes Illumina And Enterprise Products Partners
   
  
  
  January 06, 2022
  From Benzinga
 
   2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
   
  
  
  December 30, 2021
  From Benzinga
 
   Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
   
  
  
  December 20, 2021
  From Benzinga
 
   46 Biggest Movers From Yesterday
   
  
  
  December 16, 2021
  From Benzinga
 
   36 Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  December 15, 2021
  From Benzinga
 From Benzinga
 
   Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments
   
  
  
  December 13, 2021
  From Benzinga
 
   Trip to Sustainability? This Company Is Developing Synthetic Psychedelics To Attempt to Fight Mental Illness
   
  
  
  December 13, 2021
  From Benzinga
 
   Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
   
  
  
  December 09, 2021
  From Benzinga
 
   National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
   
  
  
  December 08, 2021
  From Benzinga
 
   This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness
   
  
  
  December 08, 2021
  From Benzinga
 
   New York's Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
   
  
  
  December 07, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
   
  
  
  November 30, 2021
  From Benzinga
 
   Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
   
  
  
  November 29, 2021
  From Benzinga
 
   70 Biggest Movers From Yesterday
   
  
  
  November 16, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2021
   
  
  
  November 11, 2021
  From Benzinga
 
   This Psychedelics Stock Was Up More Than 20% Last Week, Outperforming Tesla, Nvidia and GameStop
   
  
  
  November 02, 2021
  From Benzinga
 
   These 4 Psychedelic Biotech Stocks Are Leading the Pack
   
  
  
  October 26, 2021
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
